Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?

Blood advances - 12 Nov 2019

Thol Felicitas, Platzbecker Uwe

Abstract excerpt

This article has a companion Counterpoint by Sanz et al.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Decision Trees
Share to Biomarkers
Share to Clinical Decision-Making
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Management

Share to High-Throughput Nucleotide Sequencing

Share to Molecular Targeted Therapy

Share to Myelodysplastic Syndromes

Source

Open in PubMed Open full text

Identifiers

PMID: 31714960
DOI: 10.1182/bloodadvances.2018022434
PMCID: PMC6855118

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?PMID 31714960Read ↗

Evidence-Based Minireview: Molecular precision and clinical uncertainty: should molecular profiling be routinely used to guide risk stratification in MDS?Semantic proximity Read ↗

The role of next-generation sequencing in hematologic malignanciesSemantic proximity Read ↗

A novel next generation sequencing approach to improve sarcoma diagnosisSemantic proximity Read ↗

Lessons from next-generation sequencing analysis in hematological malignanciesSemantic proximity Read ↗

Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcomaSemantic proximity Read ↗

Real-world investigation of germline predisposition to myelodysplastic syndromesSemantic proximity Read ↗

Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based survey.Semantic proximity Read ↗

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022.Semantic proximity Read ↗

Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine useSemantic proximity Read ↗

[Chinese expert consensus on the clinical application of next-generation sequencing technology in myelodysplastic neoplasms (2026)].Semantic proximity Read ↗

Applications of next-generation sequencing in hematologic malignancies.Semantic proximity Read ↗

Advancing chronic myeloid leukemia research with next-generation sequencing: potential benefits, limitations, and future clinical integrationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.